Logo

PE Biosystems Files Suit Against Amersham Biotech

Jun 16, 2000
Premium

FOSTER CITY, Calif.--PE Biosystems has filed suit in the Northern District of California against Amersham Pharmacia Biotech for infringing a patent covering a class of fluorescent dye compounds developed by PE and used in automated DNA sequencing. Amersham recently was granted two favorable rulings by a California District Court in a lawsuit against PE. That dispute is about a different patent concerning energy transfer dyes.

Filed under

Informatics
Breaking News
The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.